Results 151 to 160 of about 100,532,293 (204)

Intraoperative Guidance of Pancreatic Cancer Resection Using a Toll-like Receptor 2-Targeted Fluorescence Molecular Imaging Agent. [PDF]

Cancer Res Commun
Huynh AS, Cohen AS, Doligalski M, Casagni TJ, Moberg VE, Huang X, Morse J, Abrahams D, Lloyd MC, Centeno BA, Baldwin MK, McLaughlin ML, Vagner J, Morse DL.   +13 more
europepmc   +1 more source

Study of gene polymorphisms in Toll-like receptor 2 in patients with acute lymphoblastic leukemia. [PDF]

Heliyon
Alkhulaifi FM, Alonaizan R, Rady A, Alomar S.   +3 more
europepmc   +1 more source

Impact of Mygalin on Inflammatory Response Induced by Toll-like Receptor 2 Agonists and IFN-γ Activation. [PDF]

Int J Mol Sci
Del Santos N, Vázquez-Ramírez R, Mendes E, Silva Júnior PI, Borges MM.   +4 more
europepmc   +1 more source

Immunostimulation Signaling via Toll-like Receptor 2 Activation: A Molecular Mechanism of Lactococcus lactis OTG1204 In Vitro and In Vivo. [PDF]

Nutrients
Song HA, Jang SY, Park MJ, Kim SW, Kang CG, Lee JH, Kim HJ, Kim J, Lee JK, Chung KS, Lee KT.   +10 more
europepmc   +1 more source

Esophageal microbial dysbiosis impairs mucosal barrier integrity via toll-like receptor 2 pathway in patients with gastroesophageal reflux symptoms. [PDF]

J Transl Med
Chen S, Jiang D, Zhuang Q, Hou X, Jia X, Chen J, Lin H, Zhang M, Tan N, Xiao Y.   +9 more
europepmc   +1 more source

Therapeutic potential of a systemically applied humanized monoclonal antibody targeting Toll‑like receptor 2 in atopic‑dermatitis‑like skin lesions in a mouse model. [PDF]

Biomed Rep
Yeo H, Jung E, Kim TY, Shin SY.
europepmc   +1 more source

Simplified scalable synthesis of a water-soluble toll-like receptor 2 agonistic lipopeptide adjuvant for use with protein-based viral vaccines. [PDF]

Bioorg Chem
Brar DS, Kaur A, Patil MT, Honda-Okubo Y, Petrovsky N, Salunke DB.   +5 more
europepmc   +1 more source

5-Methoxytryptophan Protects against Toll-Like Receptor 2-Mediated Renal Tissue Inflammation and Fibrosis in a Murine Unilateral Ureteral Obstruction Model. [PDF]

J Innate Immun
Wu JY, Lee GL, Chueh YF, Kuo CC, Hsu YJ, Wu KK.   +5 more
europepmc   +1 more source

GSP1-111 Modulates the Microglial M1/M2 Phenotype by Inhibition of Toll-like Receptor 2: A Potential Therapeutic Strategy for Depression. [PDF]

Int J Mol Sci
Kim RE, Mabunga DF, Boo KJ, Kim DH, Han SH, Shin CY, Kwon KJ.   +6 more
europepmc   +1 more source

[Retracted] Toll‑like receptor 2 downregulates the cholesterol efflux by activating the nuclear factor‑κB pathway in macrophages and may be a potential therapeutic target for the prevention of atherosclerosis. [PDF]

Exp Ther Med
Li Y, Shen S, Ding S, Wang L.
europepmc   +1 more source